IRF8 and hematopoietic and lymphoid cell neoplasm: IRF8 may also function in non-hematopoietic cancers to negatively regulate the expression of MMP3, a matrix metalloproteinase associated with a poor prognosis and metastasis in various solid organ cancers [159,160,161].